Statement by CDC Director Thomas R. Frieden, M.D., M.P.H., on Early End of HPTN 052 Study - Statement: May 12, 2011
Statement by CDC Director Thomas R. Frieden, M.D., M.P.H., on Early End of HPTN 052 Study
Media Type: Html
- SourceUrl: http://www.cdc.gov/media/releases/2011/s0512_earlyhivtreatment.html
- Syndication ID: 5318
- Language: English
- Source: Centers for Disease Control and Prevention (CDC)
- Date Syndication Captured: Monday, May 23, 2016 at 09:56 PM
- Date Syndication Updated: Tuesday, May 24, 2016 at 01:51 AM
Tags
General:
HIV treatment
HIV prevention
HPTN 052 Study
anti-retroviral therapy
Embed Code Snippet
To get the embed code snippet please Login.